- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4155 - 1,2-Diazoles not condensed and containing further heterocyclic rings
Patent holdings for IPC class A61K 31/4155
Total number of patents in this class: 2520
10-year publication summary
|
179
|
121
|
156
|
143
|
147
|
157
|
156
|
134
|
178
|
136
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Hua Medicine (Shanghai) Ltd. | 59 |
40 |
| Novartis AG | 10730 |
39 |
| Incyte Corporation | 1027 |
37 |
| F. Hoffmann-La Roche AG | 7941 |
36 |
| Takeda Pharmaceutical Company Limited | 2705 |
34 |
| LG Chem, Ltd. | 17644 |
24 |
| Boehringer Ingelheim International GmbH | 4642 |
24 |
| Bristol-myers Squibb Company | 4867 |
23 |
| AstraZeneca AB | 2908 |
23 |
| Daiichi Sankyo Company, Limited | 1884 |
22 |
| The Regents of the University of California | 20059 |
21 |
| Epizyme, Inc. | 374 |
21 |
| Hoffmann-La Roche Inc. | 3461 |
20 |
| Pfizer Inc. | 3368 |
20 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3183 |
20 |
| Vanderbilt University | 1914 |
20 |
| Yeda Research and Development Co. Ltd. | 1341 |
20 |
| Japan Tobacco Inc. | 3595 |
18 |
| Merck Sharp & Dohme LLC | 3760 |
18 |
| ChemoCentryx, Inc. | 384 |
17 |
| Other owners | 2023 |